Internal Medicine, Hematology & Oncology · St Petersburg, FL
NPI
1013902006
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5000 Park St N Ste 1017
St Petersburg, FL, 33709
Phone (727) 344-6569
Groups this clinician bills Medicare through
Medicare paid, 2024
$723K
66,729 services
Medicare patients, 2024
179
Average age 74
Drug cost, 2024
$8.1M
3,133 prescriptions
Company payments, 2025
$3,405
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed H Abid was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 11,730 times for 11 patients. In total Syed H Abid billed 66,729 services in 115 codes, and Medicare paid $723K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-08-31.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 11,730 | 11 | $0.27 | $3,212 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,642 | 14 | $6.57 | $17K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,040 | 13 | $0.09 | $92.26 |
| 85025 Blood Count | Office | 457 | 123 | $7.61 | $3,478 |
| 36415 Venipuncture Blood Collection | Office | 410 | 125 | $8.65 | $3,547 |
| 80053 Clinical Chemistry | Office | 206 | 83 | $10.35 | $2,132 |
| 96367 Intravenous Infusion, Hydration | Office | 156 | 14 | $20.92 | $3,263 |
| 96372 Injection Administration | Office | 152 | 36 | $10.77 | $1,637 |
| 83615 Clinical Chemistry | Office | 124 | 50 | $5.92 | $734 |
| 82728 Clinical Chemistry | Office | 114 | 63 | $13.36 | $1,523 |
| 99214 Office E&M - Established | Office | 111 | 62 | $94.42 | $10K |
| 96413 Chemotherapy Administration | Office | 110 | 15 | $93.43 | $10K |
| 83735 Clinical Chemistry | Office | 107 | 32 | $6.57 | $703 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 105 | 64 | $12.90 | $1,354 |
| 83540 Clinical Chemistry | Office | 102 | 56 | $6.34 | $647 |
By year: 2022 $604K for 45,019 services; 2023 $507K for 58,316 services; 2024 $723K for 66,729 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 457 | 123 | $7.61 | $3,478 |
| 36415 Venipuncture Blood Collection | 410 | 125 | $8.65 | $3,547 |
| 80053 Clinical Chemistry | 206 | 83 | $10.35 | $2,132 |
| 83615 Clinical Chemistry | 124 | 50 | $5.92 | $734 |
| 82728 Clinical Chemistry | 114 | 63 | $13.36 | $1,523 |
| 83735 Clinical Chemistry | 107 | 32 | $6.57 | $703 |
| 83540 Clinical Chemistry | 102 | 56 | $6.34 | $647 |
| 84100 Clinical Chemistry | 92 | 27 | $4.65 | $428 |
| 82378 Clinical Chemistry | 32 | 20 | $18.58 | $595 |
| 82607 Clinical Chemistry | 32 | 26 | $14.78 | $473 |
Medicare prescription drug claims, 2024
In 2024, the drug Syed H Abid prescribed most often to Medicare patients was Anastrozole, with 281 prescriptions and refills. In total Syed H Abid wrote 3,133 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 281 | 623 | 70 | $4,272 |
| Alendronate Sodium Generic | 163 | 335 | 40 | $879 |
| Retacrit Epoetin Alfa-Epbx | 115 | 115 | 49 | $165K |
| Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosp/Pf | 110 | 110 | 30 | $1,637 |
| Famotidine Famotidine/Pf | 108 | 108 | 30 | $234 |
| Ondansetron Odt Ondansetron | 103 | 105 | 88 | $7,037 |
| Allopurinol Generic | 102 | 266 | 49 | $1,175 |
| Procrit Epoetin Alfa | 100 | 100 | 25 | $380K |
| Omeprazole Generic | 81 | 226 | 44 | $552 |
| Hydroxyurea Generic | 79 | 136 | 19 | $1,834 |
| Morphine Sulfate Generic | 74 | 74 | 51 | $1,536 |
| Carboplatin Generic | 62 | 62 | 21 | $3,682 |
| Acyclovir Generic | 60 | 98 | 16 | $560 |
| Diphenhydramine Hcl Generic | 55 | 58 | 17 | $145 |
| Erleada Apalutamide | 54 | 54 | Under 11 | $793K |
Brand drugs: 1,096 claims; generic drugs: 2,037 claims; opioid claims: 126.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed H Abid $3,405 ($3,405 in general payments such as food, travel and fees) from 35 companies. The largest payer was Novartis Pharmaceuticals Corporation with $402.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $402 |
| Merck Sharp & Dohme LLC MRK | 12 | $297 |
| Pfizer Inc. PFE | 11 | $256 |
| Celgene Corporation BMY | 12 | $255 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $227 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $210 |
| GlaxoSmithKline, LLC. GSK | 5 | $200 |
| Incyte Corporation INCY | 7 | $179 |
| Janssen Biotech, Inc. JNJ | 7 | $160 |
| Daiichi Sankyo Inc. 4568.T | 6 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.